FDA — authorised 28 November 2017
- Application: NDA209589
- Marketing authorisation holder: FERRING PHARMS INC
- Indication: Type 3 - New Dosage Form
- Status: approved
🇺🇸 Prepopik in United States
FDA authorised Prepopik on 28 November 2017
Marketing authorisation
Prepopik in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Gastroenterology approved in United States
Frequently asked questions
Is Prepopik approved in United States?
Yes. FDA authorised it on 28 November 2017.
Who is the marketing authorisation holder for Prepopik in United States?
FERRING PHARMS INC holds the US marketing authorisation.